Benjamin Graham Warren Buffett Value investing "Price is what you pay. Value is what you get."
Warren BUFFETT Version Française - ITALIAN - PORTUGUESE - SPANISH - GERMAN - NEDERLAND		 Benjamin Graham Warren Buffett Value investing
Forums about Benjamin Graham and Value investing


Selecting value stocks with BENJAMIN GRAHAM

Screening world Countries with Benjamin Graham 's formula
- U.S.A.
- Canada
- U.K.
- France
- Germany
- Japan
- Hong-Kong

Screening world Indexes with Benjamin Graham
Screening world Sectors with Benjamin Graham
My Value Investing Stocks

Learning Value Investing with BENJAMIN GRAHAM

Value Investing with Benjamin Graham
Benjamin Graham's Formula
Benjamin Graham's filters
The Intelligent Investor by Benjamin Graham





Boiron -

- Mid&Small 190 - Pharmaceuticals

Boiron SA is a France-based pharmaceutical company engaged in the provision of homeopathic medicines. The Company develops, manufactures and markets single homeopathic medicines and proprietary drugs.

FORUMS
VISIT Boiron FORUM !
MARGIN OF SAFETY of Boiron : 56.37 %
The Margin of Safety of Boiron is OK (>50%).
How is the Margin of Safety calculated ?
QUALITY :
Conservative Investors : Earnings Stability OKDividends OKEarnings Growth OKValuation OK
Enterprising Investors : Financial Condition OKEarnings Stability OKDividends OKEarnings Growth OK
What are the Stars ?




Price over 1 year :



PRICE, INTRINSIC VALUE & MARGIN OF SAFETY based on GRAHAM's FORMULA
What is the Graham's Formula ?
Boiron price is :
(as of 5/22/2009) 		EUR
Current Earnings per Share
(2009 est.) are : 		EUR
Estimated Long Term Growth
(% per Year) is :

 %
INTRINSIC VALUE =
1.80 x (8.5 + 2 x 4.22) =

 30.49 EUR
MARGIN OF SAFETY =
(30.49 - 19.5 ) / 19.5 =

 56.37 % (OK)
How is Long Term Growth estimated for Boiron ?

Historical analysis for Boiron - See detail

QUALITATIVE FILTERS FOR Boiron
What are the Stars ?		 DEFENSIVE
Earnings Stability OKDividends OKEarnings Growth OKValuation OK		 ENTERPRISING
Financial Condition OKEarnings Stability OKDividends OKEarnings Growth OK
COMPANY SIZE (MKT CAP. Mls $) Small Cap. 593 mls.$ NO
The company's Market cap. is under 5000 millions dollars 		-
FINANCIAL CONDITION Current Ratio 1.73
The current ratio is under 2
The current ratio is above 1.5
LT Debt/Net Curr. Assets 0.02
The LTdebt/current assets ratio is under 1
The LTdebt/current assets ratio is under 1.1
EARNINGS STABILITY Losses / 10 - 5 Years 0 / 0
No losses in the past ten years
No losses in the past five years
DIVIDENDS Years of Dividends 15
15 years of dividend in the past 15 years
Current dividends paid
EARNINGS GROWTH Growth 10-5 Years 39% / 30%%
Total Earnings growth above 33% for the past 10 years
Last year earnings above earnings 5 years ago
VALUATION P.E. x P/Book 16.88
P.E. x P/Book is under 22.5
P/Book is under 1.20
P.E. 10.8 OK
PE is under 15 		-
P/Book 1.56 NO
P/Book is above 1.5		 NO
P/Book is above 1.2

Boiron - Competitors for Pharmaceuticals

 

 STOCK QUALITY
Conservative Investors 		MARGIN OF SAFETY
Long Term Growth
Price / Earnings

 
Forest Labs
- U.S.A.
SP 500
Pharmaceuticals
Financial Condition OKEarnings Stability OKEarnings Growth OKValuation OK
MARGIN OF SAFETY :
 367.14 %
Long Term Growth : 11.15 %
Price / Earnings : 6.6 x
23.08 / 3.50 =
Sanofi Aventis
- France
CAC 40
Pharmaceuticals
Earnings Growth OKValuation OK
MARGIN OF SAFETY :
 326.34 %
Long Term Growth : 11.13 %
Price / Earnings : 7.2 x
43.88 / 6.08 =
Biovail Corp
- Canada
TSE60
Pharmaceuticals
Valuation OK
MARGIN OF SAFETY :
 214.09 %
Long Term Growth : 14.34 %
Price / Earnings : 11.8 x
14.56 / 1.23 =
Pfizer
- U.S.A.
DOW JONES 30
Pharmaceuticals
Earnings Stability OKDividends OKEarnings Growth OKValuation OK
MARGIN OF SAFETY :
 212.11 %
Long Term Growth : 7.62 %
Price / Earnings : 7.6 x
14.83 / 1.95 =
Teva
- U.S.A.
Nasdaq 100
Pharmaceuticals
Earnings Stability OKEarnings Growth OK
MARGIN OF SAFETY :
 161.19 %
Long Term Growth : 13.27 %
Price / Earnings : 13.4 x
44.28 / 3.30 =
Merck
- Germany
DAX 30
Pharmaceuticals
Earnings Stability OKEarnings Growth OKValuation OK
MARGIN OF SAFETY :
 152.80 %
Long Term Growth : 10.97 %
Price / Earnings : 12.0 x
64.04 / 5.32 =
Astellas Pharma
- Tokyo
Nikkei 225
Pharmaceuticals
Earnings Stability OKDividends OKEarnings Growth OKValuation OK
MARGIN OF SAFETY :
 148.84 %
Long Term Growth : 8.38 %
Price / Earnings : 10.1 x
3260 / 321.20 =
Bayer
- Germany
DAX 30
Pharmaceuticals
Dividends OKValuation OK
MARGIN OF SAFETY :
 146.93 %
Long Term Growth : 10.23 %
Price / Earnings : 11.7 x
39.3 / 3.35 =
GlaxoSmithKline
- U.K.
FTSE 100
Pharmaceuticals
Earnings Stability OKEarnings Growth OK
MARGIN OF SAFETY :
 134.07 %
Long Term Growth : 6.36 %
Price / Earnings : 9.1 x
1063.5 / 117.33 =
Sun Pharma
- India
Nifty50
Pharmaceuticals
Financial Condition OKEarnings Stability OKEarnings Growth OK
MARGIN OF SAFETY :
 131.48 %
Long Term Growth : 13.45 %
Price / Earnings : 15.3 x
1290.6 / 84.39 =
Virbac
- France
Mid&Small 190
Pharmaceuticals
Earnings Stability OKEarnings Growth OK
MARGIN OF SAFETY :
 127.68 %
Long Term Growth : 9.52 %
Price / Earnings : 12.1 x
52.36 / 4.33 =
Eli Lilly
- U.S.A.
SP 500
Pharmaceuticals
Earnings Stability OKDividends OKEarnings Growth OK
MARGIN OF SAFETY :
 127.36 %
Long Term Growth : 5.10 %
Price / Earnings : 8.2 x
34.62 / 4.21 =
Wyeth
- U.S.A.
SP 500
Pharmaceuticals
Financial Condition OK
MARGIN OF SAFETY :
 122.12 %
Long Term Growth : 9.76 %
Price / Earnings : 12.6 x
44.03 / 3.49 =
Takeda Pharm
- Tokyo
Nikkei 225
Pharmaceuticals
Earnings Stability OKDividends OKEarnings Growth OKValuation OK
MARGIN OF SAFETY :
 122.01 %
Long Term Growth : 7.98 %
Price / Earnings : 11.0 x
3860 / 350.50 =
Abbott Labs
- U.S.A.
SP 500
Pharmaceuticals
Earnings Stability OKDividends OKEarnings Growth OK
MARGIN OF SAFETY :
 110.19 %
Long Term Growth : 8.12 %
Price / Earnings : 11.8 x
43.32 / 3.68 =
Allergan
- U.S.A.
SP 500
Pharmaceuticals
Dividends OKEarnings Growth OK
MARGIN OF SAFETY :
 106.31 %
Long Term Growth : 12.36 %
Price / Earnings : 16.1 x
43.79 / 2.72 =
Cipla Ltd
- India
Nifty50
Pharmaceuticals
Financial Condition OKEarnings Stability OKEarnings Growth OK
MARGIN OF SAFETY :
 105.63 %
Long Term Growth : 12.73 %
Price / Earnings : 16.5 x
222.95 / 13.50 =
Johnson&Johnson
- U.S.A.
DOW JONES 30
Pharmaceuticals
Earnings Stability OKEarnings Growth OK
MARGIN OF SAFETY :
 104.19 %
Long Term Growth : 8.23 %
Price / Earnings : 12.2 x
54.99 / 4.50 =
Eisai
- Tokyo
Nikkei 225
Pharmaceuticals
Earnings Stability OKDividends OKEarnings Growth OK
MARGIN OF SAFETY :
 98.52 %
Long Term Growth : 9.42 %
Price / Earnings : 13.8 x
3050 / 221.50 =
Dr Reddys Labs
- India
Nifty50
Pharmaceuticals
Financial Condition OKEarnings Stability OKEarnings Growth OK
MARGIN OF SAFETY :
 91.36 %
Long Term Growth : 10.82 %
Price / Earnings : 15.8 x
660.95 / 41.95 =
King Pharma
- U.S.A.
SP 500
Pharmaceuticals
Earnings Growth OKValuation OK
MARGIN OF SAFETY :
 89.77 %
Long Term Growth : 4.21 %
Price / Earnings : 8.9 x
8.74 / 0.98 =
Shionogi
- Tokyo
Nikkei 225
Pharmaceuticals
Earnings Stability OKDividends OKEarnings Growth OK
MARGIN OF SAFETY :
 81.75 %
Long Term Growth : 11.71 %
Price / Earnings : 17.6 x
1846 / 105.09 =
GlaxoSmith P
- India
Nifty50
Pharmaceuticals
Financial Condition OKEarnings Stability OKEarnings Growth OK
MARGIN OF SAFETY :
 71.17 %
Long Term Growth : 11.32 %
Price / Earnings : 18.2 x
1096.25 / 60.25 =
Boiron
- France
Mid&Small 190
Pharmaceuticals
Earnings Stability OKDividends OKEarnings Growth OKValuation OK
MARGIN OF SAFETY :
 56.40 %
Long Term Growth : 4.22 %
Price / Earnings : 10.8 x
19.5 / 1.80 =
Bristol Myers
- U.S.A.
SP 500
Pharmaceuticals
Financial Condition OKEarnings Stability OKDividends OK
MARGIN OF SAFETY :
 32.57 %
Long Term Growth : 2.79 %
Price / Earnings : 10.6 x
20.39 / 1.92 =
Stallergenes
- France
Mid&Small 190
Pharmaceuticals
Earnings Stability OKEarnings Growth OK
MARGIN OF SAFETY :
 2.07 %
Long Term Growth : 12.50 %
Price / Earnings : 32.8 x
47.58 / 1.45 =
Dainpn Sumi Phar
- Tokyo
Nikkei 225
Pharmaceuticals
Earnings Stability OKDividends OKEarnings Growth OKValuation OK
MARGIN OF SAFETY :
 0.00 %
Long Term Growth : 0.00 %
Price / Earnings : 20.2 x
773 / 38.30 =
DAIICHI SANKYO
- Tokyo
Nikkei 225
Pharmaceuticals
Earnings Stability OK
MARGIN OF SAFETY :
 0.00 %
Long Term Growth : 0.00 %
Price / Earnings : 28.6 x
1677 / 58.72 =
SH Dingli
- China
Shangaï-B
Pharmaceuticals
Earnings Growth OK
MARGIN OF SAFETY :
 0.00 %
Long Term Growth : 0.00 %
Price / Earnings : 11.0 x
0.44 / 0.04 =
Cardiome Pharma
- Canada
SP/TSX Comp.
Pharmaceuticals
Financial Condition OK
MARGIN OF SAFETY :
 0.00 %
Long Term Growth : 0.00 %
Price / Earnings : -13.7 x
4.66 / -0.34 =
Ipsen
- France
Mid&Small 190
Pharmaceuticals
Financial Condition OKEarnings Stability OK
MARGIN OF SAFETY :
 0.00 %
Long Term Growth : 0.00 %
Price / Earnings : 19.3 x
32.17 / 1.67 =
Merck
- U.S.A.
DOW JONES 30
Pharmaceuticals
Earnings Stability OKDividends OK
MARGIN OF SAFETY :
 0.00 %
Long Term Growth : 0.00 %
Price / Earnings : 8.1 x
26.12 / 3.22 =
Sepracor
- U.S.A.
Nasdaq 100
Pharmaceuticals
Valuation OK
MARGIN OF SAFETY :
 0.00 %
Long Term Growth : 0.00 %
Price / Earnings : 5.7 x
14.23 / 2.48 =
Schering Plough
- U.S.A.
SP 500
Pharmaceuticals
MARGIN OF SAFETY :
 0.00 %
Long Term Growth : 0.00 %
Price / Earnings : 13.8 x
23.68 / 1.72 =
Shire
- U.K.
FTSE 100
Pharmaceuticals
MARGIN OF SAFETY :
 0.00 %
Long Term Growth : 0.00 %
Price / Earnings : 859.3 x
876.5 / 1.02 =
UCB
- Belgium
BEL20
Pharmaceuticals
Earnings Stability OKValuation OK
MARGIN OF SAFETY :
 0.00 %
Long Term Growth : 0.00 %
Price / Earnings : 18.5 x
22.93 / 1.24 =
Watson Pharma
- U.S.A.
SP 500
Pharmaceuticals
Financial Condition OKValuation OK
MARGIN OF SAFETY :
 0.00 %
Long Term Growth : 0.00 %
Price / Earnings : 12.3 x
29.85 / 2.42 =
CHUGAI PHARM
- Tokyo
Nikkei 225
Pharmaceuticals
Earnings Stability OKEarnings Growth OK
MARGIN OF SAFETY :
 -17.60 %
Long Term Growth : 5.62 %
Price / Earnings : 24.0 x
1787 / 74.60 =
Kyowa Hakko K
- Tokyo
Nikkei 225
Pharmaceuticals
Financial Condition OKEarnings Stability OKDividends OKEarnings Growth OK
MARGIN OF SAFETY :
 -44.33 %
Long Term Growth : 6.47 %
Price / Earnings : 38.5 x
966 / 25.09 =
Ranbaxy Labs
- India
Nifty50
Pharmaceuticals
Financial Condition OKEarnings Stability OKEarnings Growth OK
MARGIN OF SAFETY :
 -85.47 %
Long Term Growth : 0.32 %
Price / Earnings : 62.9 x
220.25 / 3.50 =
AstraZeneca
- U.K.
FTSE 100
Pharmaceuticals
Earnings Stability OK
MARGIN OF SAFETY :
 -94.72 %
Long Term Growth : 9.83 %
Price / Earnings : 533.5 x
2646 / 4.96 =


Sites partenaires :
COMPARATIF ASSURANCES-VIE : Fortuneo, Boursorama, ING, BforBank, Monabanq...

COMPARATIF LIVRETS : ING, BforBank, Fortueno, VTB Banque...

ANNUAIRE DES CONSEILS EN ASSURANCE : Auto, Santé, Habitation, Epargne...

  Links - Site Map